OPPENHEIMER & CO INC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 822581 NEW YORK, NY

Position in NTLA

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$1,370,765

+$425,332 QoQ

Shares Held

106,924

+1.7% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OPPENHEIMER & CO INC holds $44,352,224 across 44 Biotechnology names. NTLA ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	22,477	$17,366,629
2	VKTX	Viking Therapeutics, Inc.	150,133	$4,885,327
3	TYRA	Tyra Biosciences, Inc.	84,192	$3,224,553
4	CAPR	Capricor Therapeutics, Inc.	63,666	$1,935,446
5	VRTX	Vertex Pharmaceuticals Inc / Ma	4,308	$1,923,694
6	CPRX	Catalyst Pharmaceuticals, Inc.	68,116	$1,686,552
7	NTLA	Intellia Therapeutics, Inc. This page	106,924	$1,370,765
8	TRVI	Trevi Therapeutics, Inc.	100,027	$1,193,322

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,370,765	106,924	+1.7%	Shares	Sole	2026-04-24
2025-12-31	$945,433	105,165	+0.8%	Shares	Sole	2026-02-02
2025-09-30	$1,802,245	104,357	-1.7%	Shares	Sole	2025-11-06
2025-06-30	$996,287	106,214	+467.7%	Shares	Sole	2025-07-31
2025-03-31	$133,013	18,708	+4.6%	Shares	Sole	2025-04-23
2024-12-31	$208,539	17,885	+129.0%	Shares	Sole	2025-02-05
2023-09-30	$246,952	7,810	-4.5%	Shares	Sole	2023-11-08
2023-06-30	$333,661	8,182	+348.6%	Shares	Sole	2023-08-03
2021-09-30	$244,689	1,824	-19.7%	Shares	Sole	2021-11-12
2021-06-30	$367,697	2,271	—	Shares	Sole	2021-08-03
No filing history on record for this holder in this stock.